Cargando…

Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma

Rationale: Currently, for locoregionally advanced nasopharyngeal carcinoma (LA-NPC), there is no effective blood-based method to predict distant metastasis. We aimed to detect plasma protein profiles to identify biomarkers that could distinguish patients with NPC who are at high risk of posttreatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yelin, Li, Junyan, Li, Qian, Tang, Linglong, Chen, Lei, Mao, Yanping, He, Qingmei, Yang, Xiaojing, Lei, Yuan, Hong, Xiaohong, Zhao, Yin, He, Shiwei, Guo, Ying, Wang, Yaqin, Zhang, Panpan, Liu, Na, Li, Yingqin, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449924/ https://www.ncbi.nlm.nih.gov/pubmed/32863958 http://dx.doi.org/10.7150/thno.47882

Ejemplares similares

Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1
por: Hong, Xiaohong, et al.
Publicado: (2020)

CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2015)

m(6)A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression
por: Zhang, Panpan, et al.
Publicado: (2018)

Protein C receptor maintains cancer stem cell properties via activating lipid synthesis in nasopharyngeal carcinoma
por: Zhang, Panpan, et al.
Publicado: (2022)

Correction: m(6)A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression
por: Zhang, Panpan, et al.
Publicado: (2022)

A gene expression-based immune content predictor for survival and postoperative radiotherapy response in head and neck cancer
por: Li, Yingqin, et al.
Publicado: (2021)

Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis
por: Wen, Xin, et al.
Publicado: (2016)

Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma
por: Li, Yingqin, et al.
Publicado: (2016)

TRIM21–SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis
por: Zhang, Panpan, et al.
Publicado: (2020)

USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma
por: Chen, Yang, et al.
Publicado: (2022)

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma
por: Li, Yingqin, et al.
Publicado: (2015)

Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy
por: Li, An-Chuan, et al.
Publicado: (2015)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Li, Wen-Fei, et al.
Publicado: (2016)

Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer
por: Zhang, Wenna, et al.
Publicado: (2015)

MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma
por: Hu, Yu-Jun, et al.
Publicado: (2023)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Li, Ying, et al.
Publicado: (2023)

HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma
por: Ren, Xianyue, et al.
Publicado: (2017)

Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model
por: Liu, Wei, et al.
Publicado: (2021)

A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma
por: Liang, Ye-Lin, et al.
Publicado: (2022)

miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways
por: He, Qingmei, et al.
Publicado: (2015)

Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2015)

Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients
por: Chen, Xiaoqian, et al.
Publicado: (2016)

Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma
por: Lan, Xiao-Wen, et al.
Publicado: (2016)

N(6)‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation
por: Zhao, Yin, et al.
Publicado: (2022)

Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
por: Liu, Zhenyu, et al.
Publicado: (2020)

Induction chemotherapy followed by concurrent chemoradiotherapy is benefit for advanced stage nasopharyngeal carcinoma with different nonkeratinizing carcinoma subtypes
por: Zang, Jian, et al.
Publicado: (2018)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy
por: Lv, Jia‐Wei, et al.
Publicado: (2018)

The Clinical Utility of Plasma Epstein–Barr Virus DNA Assays in Nasopharyngeal Carcinoma: The Dawn of a New Era?: A Systematic Review and Meta-Analysis of 7836 Cases
por: Zhang, Wenna, et al.
Publicado: (2015)

The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma
por: Li, Xiao‐Min, et al.
Publicado: (2022)

Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
por: Chen, Ming-Yuan, et al.
Publicado: (2013)

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?
por: Yao, Ji-Jin, et al.
Publicado: (2019)

Importance of maintaining body weight for prevention of distant metastasis of nasopharyngeal carcinoma: An alternative workflow for cancer-risk assessment
por: Zhang, Wenna, et al.
Publicado: (2017)

TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells
por: Xie, Changqing, et al.
Publicado: (2020)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
por: Lv, Shu-Hui, et al.
Publicado: (2021)

Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy
por: Wu, Ming-Yao, et al.
Publicado: (2016)

Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
por: Wu, Yuan, et al.
Publicado: (2020)

Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology
por: Wang, Ya-Qin, et al.
Publicado: (2020)

A Four-Gene Signature Model Improves the Prediction of Distant Metastasis in Patients with Nasopharyngeal Carcinoma: A Retrospective, Three-Center Observational Study
por: Si, Jinyuan, et al.
Publicado: (2022)

Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large‐population retrospective analysis
por: Qu, Weiling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g6hfvdcp6l6tbv3suo4pch5681